BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 30723143)

  • 1. Activated and Exhausted MAIT Cells Foster Disease Progression and Indicate Poor Outcome in Hepatocellular Carcinoma.
    Duan M; Goswami S; Shi JY; Wu LJ; Wang XY; Ma JQ; Zhang Z; Shi Y; Ma LJ; Zhang S; Xi RB; Cao Y; Zhou J; Fan J; Zhang XM; Gao Q
    Clin Cancer Res; 2019 Jun; 25(11):3304-3316. PubMed ID: 30723143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exhaustion in tumor-infiltrating Mucosal-Associated Invariant T (MAIT) cells from colon cancer patients.
    Rodin W; Sundström P; Ahlmanner F; Szeponik L; Zajt KK; Wettergren Y; Bexe Lindskog E; Quiding Järbrink M
    Cancer Immunol Immunother; 2021 Dec; 70(12):3461-3475. PubMed ID: 33885944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leveraging Public Single-Cell and Bulk Transcriptomic Datasets to Delineate MAIT Cell Roles and Phenotypic Characteristics in Human Malignancies.
    Yao T; Shooshtari P; Haeryfar SMM
    Front Immunol; 2020; 11():1691. PubMed ID: 32849590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin.
    Ruf B; Bruhns M; Babaei S; Kedei N; Ma L; Revsine M; Benmebarek MR; Ma C; Heinrich B; Subramanyam V; Qi J; Wabitsch S; Green BL; Bauer KC; Myojin Y; Greten LT; McCallen JD; Huang P; Trehan R; Wang X; Nur A; Murphy Soika DQ; Pouzolles M; Evans CN; Chari R; Kleiner DE; Telford W; Dadkhah K; Ruchinskas A; Stovroff MK; Kang J; Oza K; Ruchirawat M; Kroemer A; Wang XW; Claassen M; Korangy F; Greten TF
    Cell; 2023 Aug; 186(17):3686-3705.e32. PubMed ID: 37595566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosa-associated invariant T cells infiltrate hepatic metastases in patients with colorectal carcinoma but are rendered dysfunctional within and adjacent to tumor microenvironment.
    Shaler CR; Tun-Abraham ME; Skaro AI; Khazaie K; Corbett AJ; Mele T; Hernandez-Alejandro R; Haeryfar SMM
    Cancer Immunol Immunother; 2017 Dec; 66(12):1563-1575. PubMed ID: 28798979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated but impaired IFN-γ production of mucosal-associated invariant T cells in patients with hepatocellular carcinoma.
    Huang W; Ye D; He W; He X; Shi X; Gao Y
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34789552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory mucosa-associated invariant T cells controlled by β1 adrenergic receptor signaling contribute to hepatocellular carcinoma progression.
    Fu S; Liu M; Zhu C; Zhang H; Zhao C; Xie Y; Chen G; Sheng D; Pan J; He Z; Dai Y; Gao Y; Li X; Chen L; Qian Y; Jin T; Sun C; Tian Z; Wang H; Bai L
    Hepatology; 2023 Jul; 78(1):72-87. PubMed ID: 36626624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease of CD69 levels on TCR Vα7.2
    Yong YK; Tan HY; Saeidi A; Rosmawati M; Atiya N; Ansari AW; Rajarajeswaran J; Vadivelu J; Velu V; Larsson M; Shankar EM
    Innate Immun; 2017 Jul; 23(5):459-467. PubMed ID: 28606013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-Hepatic Depletion of Mucosal-Associated Invariant T Cells in Hepatitis C Virus-Induced Liver Inflammation.
    Bolte FJ; O'Keefe AC; Webb LM; Serti E; Rivera E; Liang TJ; Ghany M; Rehermann B
    Gastroenterology; 2017 Nov; 153(5):1392-1403.e2. PubMed ID: 28780074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal-Associated Invariant T (MAIT) Cells Are Highly Activated and Functionally Impaired in COVID-19 Patients.
    Deschler S; Kager J; Erber J; Fricke L; Koyumdzhieva P; Georgieva A; Lahmer T; Wiessner JR; Voit F; Schneider J; Horstmann J; Iakoubov R; Treiber M; Winter C; Ruland J; Busch DH; Knolle PA; Protzer U; Spinner CD; Schmid RM; Quante M; Böttcher K
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33546489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal associated invariant T cells from human breast ducts mediate a Th17-skewed response to bacterially exposed breast carcinoma cells.
    Zumwalde NA; Haag JD; Gould MN; Gumperz JE
    Breast Cancer Res; 2018 Sep; 20(1):111. PubMed ID: 30208917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and predictive value of MAIT cells in non-small cell lung cancer for immunotherapy.
    Shi L; Lu J; Zhong D; Song M; Liu J; You W; Li WH; Lin L; Shi D; Chen Y
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36657812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal-Associated Invariant T Cells Are More Activated in Chronic Hepatitis B, but Not Depleted in Blood: Reversal by Antiviral Therapy.
    Boeijen LL; Montanari NR; de Groen RA; van Oord GW; van der Heide-Mulder M; de Knegt RJ; Boonstra A
    J Infect Dis; 2017 Nov; 216(8):969-976. PubMed ID: 28968772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1
    Ye L; Zhang Q; Cheng Y; Chen X; Wang G; Shi M; Zhang T; Cao Y; Pan H; Zhang L; Wang G; Deng Y; Yang Y; Chen G
    J Immunother Cancer; 2018 Dec; 6(1):145. PubMed ID: 30526680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent reduction of mucosal-associated invariant T cells in primary biliary cholangitis.
    Setsu T; Yamagiwa S; Tominaga K; Kimura N; Honda H; Kamimura H; Tsuchiya A; Takamura M; Terai S
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1286-1294. PubMed ID: 29266628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal-Associated Invariant T cell in liver diseases.
    Zhang Y; Kong D; Wang H
    Int J Biol Sci; 2020; 16(3):460-470. PubMed ID: 32015682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.
    Liu F; Zeng G; Zhou S; He X; Sun N; Zhu X; Hu A
    Bull Cancer; 2018 May; 105(5):493-501. PubMed ID: 29576222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer.
    Won EJ; Ju JK; Cho YN; Jin HM; Park KJ; Kim TJ; Kwon YS; Kee HJ; Kim JC; Kee SJ; Park YW
    Oncotarget; 2016 Nov; 7(46):76274-76290. PubMed ID: 27517754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic definition of human mucosal-associated invariant T cells determines their unique molecular effector phenotype.
    Bulitta B; Zuschratter W; Bernal I; Bruder D; Klawonn F; von Bergen M; Garritsen HSP; Jänsch L
    Eur J Immunol; 2018 Aug; 48(8):1336-1349. PubMed ID: 29749611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Mucosa-Associated Invariant T Cells Accumulate in Colon Adenocarcinomas but Produce Reduced Amounts of IFN-γ.
    Sundström P; Ahlmanner F; Akéus P; Sundquist M; Alsén S; Yrlid U; Börjesson L; Sjöling Å; Gustavsson B; Wong SB; Quiding-Järbrink M
    J Immunol; 2015 Oct; 195(7):3472-81. PubMed ID: 26297765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.